Roche (OTCQX:RHHBY) and Novartis (NYSE:NVS) are scheduled to meet with Swiss government officials this week amid U.S. President Donald Trump's repeated threats to impose tariffs on pharmaceutical ...

The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...

The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump administration calls for the industry to cut prices.

Swiss drugmaker Roche reported better than expected first-half operating profit on Thursday, driven by strong sales of breast cancer and asthma treatments.

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, its latest investment in one of the most failure-prone areas of drugmaking ...

L’Oreal’s dermatology brand has leveraged its expertise to warn young people about the consequences of sun exposure via ...

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...